To counteract the deleterious effects of DNA damage, cells are equipped with specialized polymerases to bypass DNA lesions. Previous biochemical studies revealed that DinB family DNA polymerases, including Escherichia coli DNA polymerase IV and human DNA polymerase , efficiently incorporate the correct nucleotide opposite some N DNA is susceptible to damage by endogenous and exogenous agents (1). To minimize cell death arising from replication blockage and mutations emanating from nucleotide misincorporation opposite the damage site, cells are equipped with several pathways to repair DNA lesions (2). Additionally, cells have evolved two major mechanisms to tolerate unrepaired DNA lesions (3), including homologous recombination and translesion synthesis (TLS) 2 (3). In this regard, synthesis past many DNA lesions requires the replacement of replicative DNA polymerases with one or a few specialized polymerases, most of which belong to the Y-family (4). Along this line, phylogenetic analysis revealed five branches of Y-family polymerases, which include UmuC, DinB, polymerase , polymerase , and REV1 (4, 5). All of these, except for UmuC, are found in eukaryotic cells (4,5). Apart from the Y-family DNA polymerases, some B-family DNA polymerases also participate in TLS. These include DNA polymerase II in Escherichia coli and polymerase , which is composed of the catalytic subunit REV3 and the regulatory subunit REV7, in eukaryotic cells (4, 5). These specialized DNA polymerases are characterized by their relatively low fidelity in replicating undamaged DNA but have the capability to bypass those DNA lesions that normally block DNA synthesis by replicative DNA polymerases (4). It was advocated that specialized DNA polymerases are evolved by nature to copy DNA base damage accurately, but they no longer bear the ability to replicate unmodified DNA with high fidelity (6). The best known example of this is the efficient and accurate bypass of cis,syn-cyclobutane pyrimidine dimers by polymerase (7,8), which is encoded by the xeroderma pigmentosum-variant gene (i.e. POLH) in humans (9). Xeroderma pigmentosum-variant patients exhibit elevated susceptibility to developing skin cancer (10). Several recent studies also demonstrated that DinB DNA polymerase, a Y-family polymerase conserved in all three kingdoms of life (11), can insert the correct dCMP opposite several N 2 -substituted guanine lesions at an efficiency that is similar to or better than opposite an unmodified guanine (12)(13)(14). The x-ray crystal structure of the catalytic core of human DNA polymerase , along with primer/template DNA and an incoming nucleotide, reveals the lack of steric hindrance in the minor groove at the primer-template junction (15), which may account for the tolerance of polymerase toward the minor groove N 2 -dG lesions. By using shuttle vector technology, we also showed that DinB (i.e. polymerase IV) is the major polymerase involved in the accurate bypass of the two diastereomers of N 2 -(1-carboxyethyl)-2Ј-deoxyguanosine (N 2 -CEdG) in ...